KRRO is trading 5.1% up at $12.79 as investors react to a series of bullish analyst upgrades and rising price targets for the biotech firm.
- The stock is significantly outperforming the broader market, which is currently trading lower, fueled by sustained optimism regarding its RNA-editing pipeline.
- Today's upward move builds on momentum from yesterday’s pre-market strength and reflects increasingly positive sentiment across Wall Street coverage.